Type 2 Diabetes Market Report

Global and Region Type 2 Diabetes Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：138
  • REPORT CODE：GMM997700
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.

    The dramatic increase in the prevalence, progressive nature and diagnosis of type 2 diabetes is the main driver of this rapid growth rate. The rise in disease-related comorbidities has also fuelled a more aggressive approach to treatment, including the use of multiple-drug therapies.The Americas dominated the global type 1 diabetes drug market and accounted for close to 50% of the global type 1 diabetes market size. The US was the largest revenue contributor to the diabetes drug market in this region because of the growing prevalence of the disease and rise in obesity. The accessibility to therapies by reimbursement programs is further expected to drive the growth of the diabetes drug market size in the Americas.

    The report details the trend, potential and market size of Type 2 Diabetes market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Type 2 Diabetesmarket, defines the market attractiveness level of Type 2 Diabetes market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Type 2 Diabetes industry, describes the types of Type 2 Diabetes market, the applications of major players and the market size, and deeply analyzes the current situation of the global Type 2 Diabetes market and the development prospects and opportunities of Type 2 Diabetes industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Type 2 Diabetes market in Chapter 13.

    By Player:

    • Eli Lily

    • Biocon

    • Astellas Pharma

    • Boehringer Ingelheim

    • Novo Nordisk

    • Merck

    • Sanofi

    • AstraZeneca

    • Daiichi Sankyo

    By Type:

    • Insulins

    • DPP-4 Inhibitors

    • GLP-1 Receptor Agonists

    • SGLT-2 Inhibitors

    By End-User:

    • Drugstore

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Type 2 Diabetes Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Type 2 Diabetes Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Type 2 Diabetes Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Type 2 Diabetes Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Type 2 Diabetes Market Analysis and Outlook to 2022

    • 7.1 Global Type 2 Diabetes Consumption (2017-2022)

    • 7.2 United States Type 2 Diabetes Consumption (2017-2022)

    • 7.3 Europe Type 2 Diabetes Consumption (2017-2022)

    • 7.4 China Type 2 Diabetes Consumption (2017-2022)

    • 7.5 Japan Type 2 Diabetes Consumption (2017-2022)

    • 7.6 India Type 2 Diabetes Consumption (2017-2022)

    • 7.7 South Korea Type 2 Diabetes Consumption (2017-2022)

    8 Region and Country-wise Type 2 Diabetes Market Analysis and Outlook to 2028

    • 8.1 Global Type 2 Diabetes Consumption Forecast (2022-2028)

    • 8.2 United States Type 2 Diabetes Consumption Forecast (2022-2028)

    • 8.3 Europe Type 2 Diabetes Consumption Forecast (2022-2028)

    • 8.4 China Type 2 Diabetes Consumption Forecast (2022-2028)

    • 8.5 Japan Type 2 Diabetes Consumption Forecast (2022-2028)

    • 8.6 India Type 2 Diabetes Consumption Forecast (2022-2028)

    • 8.7 South Korea Type 2 Diabetes Consumption Forecast (2022-2028)

    9 Global Type 2 Diabetes Market Outlook by Types and Applications to 2022

    • 9.1 Global Type 2 Diabetes Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Insulins Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global DPP-4 Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global GLP-1 Receptor Agonists Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global SGLT-2 Inhibitors Consumption and Growth Rate (2017-2022)

    • 9.2 Global Type 2 Diabetes Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Drugstore Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Type 2 Diabetes Market Outlook by Types and Applications to 2028

    • 10.1 Global Type 2 Diabetes Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Insulins Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global DPP-4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global GLP-1 Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global SGLT-2 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Type 2 Diabetes Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Drugstore Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Type 2 Diabetes Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Type 2 Diabetes Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Type 2 Diabetes Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Type 2 Diabetes Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Type 2 Diabetes Market Competitive Analysis

    • 14.1 Eli Lily

      • 14.1.1 Eli Lily Company Details

      • 14.1.2 Eli Lily Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eli Lily Type 2 Diabetes Product and Service

    • 14.2 Biocon

      • 14.2.1 Biocon Company Details

      • 14.2.2 Biocon Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Biocon Type 2 Diabetes Product and Service

    • 14.3 Astellas Pharma

      • 14.3.1 Astellas Pharma Company Details

      • 14.3.2 Astellas Pharma Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Astellas Pharma Type 2 Diabetes Product and Service

    • 14.4 Boehringer Ingelheim

      • 14.4.1 Boehringer Ingelheim Company Details

      • 14.4.2 Boehringer Ingelheim Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Boehringer Ingelheim Type 2 Diabetes Product and Service

    • 14.5 Novo Nordisk

      • 14.5.1 Novo Nordisk Company Details

      • 14.5.2 Novo Nordisk Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novo Nordisk Type 2 Diabetes Product and Service

    • 14.6 Merck

      • 14.6.1 Merck Company Details

      • 14.6.2 Merck Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck Type 2 Diabetes Product and Service

    • 14.7 Sanofi

      • 14.7.1 Sanofi Company Details

      • 14.7.2 Sanofi Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi Type 2 Diabetes Product and Service

    • 14.8 AstraZeneca

      • 14.8.1 AstraZeneca Company Details

      • 14.8.2 AstraZeneca Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 AstraZeneca Type 2 Diabetes Product and Service

    • 14.9 Daiichi Sankyo

      • 14.9.1 Daiichi Sankyo Company Details

      • 14.9.2 Daiichi Sankyo Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Daiichi Sankyo Type 2 Diabetes Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Type 2 Diabetes

    • Figure Type 2 Diabetes Picture

    • Table Global Type 2 Diabetes Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Type 2 Diabetes Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Type 2 Diabetes Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Type 2 Diabetes Consumption by Country (2017-2022)

    • Figure United States Type 2 Diabetes Consumption and Growth Rate (2017-2022)

    • Table Europe Type 2 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure China Type 2 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Japan Type 2 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure India Type 2 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure South Korea Type 2 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Type 2 Diabetes Consumption Forecast by Country (2022-2028)

    • Figure United States Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulins Consumption and Growth Rate (2017-2022)

    • Figure Global DPP-4 Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global GLP-1 Receptor Agonists Consumption and Growth Rate (2017-2022)

    • Figure Global SGLT-2 Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Drugstore Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Insulins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DPP-4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global GLP-1 Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global SGLT-2 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drugstore Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Type 2 Diabetes Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Type 2 Diabetes Export by Region (Top 5 Countries) (2017-2028)

    • Table Eli Lily (Foundation Year, Company Profile and etc.)

    • Table Eli Lily Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lily Type 2 Diabetes Product and Service

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Type 2 Diabetes Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Type 2 Diabetes Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Type 2 Diabetes Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Type 2 Diabetes Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Type 2 Diabetes Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Type 2 Diabetes Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Type 2 Diabetes Product and Service

    • Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Type 2 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Type 2 Diabetes Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US